Skip to main content
. 2021 Dec 7;5(23):5179–5189. doi: 10.1182/bloodadvances.2021004765

Table 3.

Association between risk factors and OS from first progression in validation cohort, by multivariable analysis

Variable HR (95% CI) P
MIPI risk score
 High 3.58 (2.24-5.71) <.001
 Intermediate 1.49 (0.94-2.36) .090
 Low
Time to POD
 PRF/POD6 3.39 (2.04-5.65) <.001
 POD6-24 1.54 (1.01-2.35) .046
 POD>24

n = 168 patients.